Artelo Biosciences announces 9.475 million USD private placement to launch Solana financial strategy

Artelo Biosciences, listed on Nasdaq, revealed a private placement of 9.475 million USD for launching its financial strategy based on the Solana blockchain. RF Lafferty & Co., Inc. Is the sole underwriter, positioning Artelo as a leader in embracing Solana as a core reserve asset.